Insilico Medicine has integrated its AI-powered drug discovery tools (TargetPro and TargetBench 1.0) into a unified framework to improve early-stage drug development accuracy and scalability.
← News
Science Breakthroughs Science Breakthroughs Knowledge
AI drug target platform pairs prediction with benchmarking to improve early discovery
TargetPro + TargetBench 1.0 Unified System Platform integration
Generative AI For Drug Target Discovery Technology type
Clinical-Stage Biotechnology Company stage